Wen-Quan Zhou
Overview
Explore the profile of Wen-Quan Zhou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
218
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yi X, He H, Xu S, Zeng T, Han D, Zhou W, et al.
Zhonghua Nan Ke Xue
. 2023 Oct;
28(12):1065-1070.
PMID: 37846625
Objective: To investigate the long-term effect of finasteride (FS) on high-risk BPH patients after treated by implantation of thermo-expandable spiral prostatic stent (TESPS). Methods: We retrospectively analyzed the clinical data...
2.
He H, Yi X, Xu S, Qu L, Zhou S, Zhang Z, et al.
Zhonghua Nan Ke Xue
. 2020 Mar;
25(5):414-419.
PMID: 32216226
Objective: To investigate the surgical techniques and clinical effect of Memokath transurethral spiral thermo-expandable prostatic stent (STEPS) implantation in the treatment of BPH. Methods: From January 2017 to January 2018,...
3.
Qu L, Wang Z, Chen Q, Li Y, He H, Hsieh J, et al.
Eur Urol
. 2018 Aug;
74(6):756-763.
PMID: 30143382
Background: Long non-coding RNAs (lncRNAs) can be used as prognostic biomarkers in many types of cancer. Objective: We sought to establish an lncRNA signature to improve postoperative risk stratification for...
4.
Lin X, Hu H, Liu Y, Hu X, Fan X, Zou W, et al.
Int J Mol Med
. 2017 Apr;
39(6):1452-1460.
PMID: 28440421
Allicin is considered anti-atherosclerotic due to its antioxidant and anti-inflammatory effects, which makes it an important drug for the prevention and treatment of atherosclerosis. However, the effects of allicin on...
5.
Xu S, Yi X, Zhang Z, Ge J, Zhou W
Mol Med Rep
. 2016 Oct;
14(6):5025-5032.
PMID: 27779679
MicroRNAs (miRNAs) are a class of small, well-conserved, non-coding RNAs that are increasingly identified as diagnostic and prognostic biomarkers in a number of cancers. Deregulated miR‑129 is closely associated with...
6.
Ding L, Ge J, Zhou W, Gao J, Zhang Z, Xiong Y
Biosens Bioelectron
. 2016 May;
85:212-219.
PMID: 27179136
This work reports on a new impedimetric immunosensing strategy for sensitive detection of prostate-specific antigen (PSA) in biological fluids. The assay was carried out on monoclonal anti-PSA capture antibody-modified glassy...
7.
Xu S, Yi X, Tang C, Ge J, Zhang Z, Zhou W
Oncol Rep
. 2016 May;
36(1):10-22.
PMID: 27176634
Long non-coding RNAs (lncRNAs) have been identified to be critical mediators in various tumors associated with cancer progression. Long non-coding RNA activated by TGF-β (lncRNA-ATB) is a stimulator of epithelial-mesenchymal...
8.
Xu S, Yi X, Zhou W, Cheng W, Ge J, Zhang Z
Int J Clin Exp Pathol
. 2016 Jan;
8(11):14335-44.
PMID: 26823749
Objective: The present study was designed to explore the clinical values of microRNA-129 (miR-129) expression in peripheral blood mononuclear cells for prostate cancer patients and the role of miR-129 in...
9.
Tang H, Wei W, Zhang Z, Zhou W, Xu S, Xu F, et al.
Zhonghua Nan Ke Xue
. 2016 Jan;
21(12):1106-9.
PMID: 26817304
Objective: To compare robot-assisted laparoscopic radical prostatectomy (RALRP) with laparoscopic radical prostatectomy (LRP) in the treatment of prostate cancer and investigate the clinical application value of RLRP. Methods: We retrospectively...
10.
Xu S, Ge J, Zhou W, Zhang Z
Zhonghua Nan Ke Xue
. 2014 Sep;
20(8):684-9.
PMID: 25195362
Objective: To examine the effect of ONO-AE3-208, an EP4 antagonist, on the formation of bone metastasis from prostate cancer in mice. Methods: Thirty-four 6-week old nude mice were divided into...